InvestSMART

Medibank Private Limited (ASX: MPL) - ETF Exposure

- Current share price for MPL : $4.930

Medibank Private Limited (MPL) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a private health insurer, underwriter and distributes private health insurance policies under its two brands, Medibank and ahm. The Group also provides a range of virtual health, home care, preventative health and primary care services through its Amplar Health division, which includes the Myhealth medical clinics.

MPL General Information +

ASX Code MPL
Website N/A
Industry/Sector Life & Health Insurance
Market Cap ($M) 13,577
MPL Share Price $4.930
Day High $4.935
Day Low $4.820
Last Close $4.930
MPL Share Price Movement - ( No change )
Prices as at 16:40, 22 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to MPL

As one of Australia's largest companies by market capitalisation, MPL is held across 45 ETFs spanning strategies that include life & health insurance exposure . Its weighting in those funds means performance can have an outsized influence - when MPL moves, funds like IMLC, AMVE, AASF, FAIR and EIGA that hold it can move with it.

For more concentrated exposure, ETFs such as IMLC (Investors Mutual Concentrated Australian Share Fund (Quoted Managed Fund)) allocate about 4.9% to MPL , while the average exposure across all 45 ETFs that hold it is around 1.2% .

Top ETF holdings

Last updated: ETF data and holdings as at 22 October 2026

Own MPL directly or through an ETF?

How does holding Medibank Private Limited (MPL) shares directly compare to ETFs that include it?

MPL Direct
IMLC
ASX 		AMVE
CBOE 		AASF
ASX 		FAIR
ASX 		EIGA
ASX
Holdings 1 company 13 holdings 63 holdings 37 holdings 83 holdings 38 holdings
MPL Weight 100% 4.9% 4.6% 3.2% 2.5% 2.5%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.99% p.a. 0.55% p.a. 0.78% p.a. 0.49% p.a. 0.65% p.a.
Approx. Yield 3.9% 8.43% - 6.69% 3.09% 5.65%
Star Ratings - star starstar starstar starstarstarstar star

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not MPL's direct yield. Annual cost uses each ETF's MER.

MPL Exposure on $10,000 investment

How a $10,000 investment in Medibank Private Limited (MPL) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Medibank Private Limited (MPL) Direct share $4.930 3.14% +$314 $10,314
Investors Mutual Concentrated Australian Share Fund (Quoted Managed Fund) (IMLC) Equity - Australia Strategy $3.980 3.38% +$338 $10,338
AB Managed Volatility Equities Fund - MVE Class - Active ETF (AMVE) Equity - Australia Strategy $1.815 0% $0 $10,000
Airlie Australian Share Fund (Managed Fund) (AASF) Equity - Australia Strategy $3.810 1.06% +$106 $10,106
BetaShares Australian Sustainability Leaders ETF (FAIR) Equity - Australia Strategy $18.720 2.24% +$224 $10,224
Perennial Income Generator Fund (Managed Fund) (EIGA) Equity - Australia Strategy $3.790 0.80% +$80 $10,080

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Medibank Private Limited (MPL) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 10.9¢ 100% 2 Sep 2026 8 Oct 2026 - - -
Result 8.3¢ 100% 26 Feb 2026 18 Mar 2026 - - -
HFResult 10.2¢ 100% 10 Sep 2025 9 Oct 2025 - - -

See all dividends from Medibank Private Limited (MPL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Medibank Private Limited (MPL) price-sensitive announcements

MPL - FY26 Results - Investor Presentation
Medibank Private Limited's FY26 results showcase a strong financial performance, with a 30
Medibank Private Limited (MPL)
20 Aug 2026 | 7:50 AM
MPL - FY26 Results - Media Release
Medibank Private Limited reported its FY26 financial results highlighting a 6.7% increase
Medibank Private Limited (MPL)
20 Aug 2026 | 7:49 AM
MPL - FY26 Appendix 4E, Financial Report and Sustainability Report
The document pertains to Medibank Private Limited's financial results for the fiscal year
Medibank Private Limited (MPL)
20 Aug 2026 | 7:45 AM
MPL - HY26 Results - Investor Presentation
Medibank Private Limited's HY26 results showcase a solid financial performance with a grou
Medibank Private Limited (MPL)
19 Feb 2026 | 7:41 AM

Medibank Private Limited (MPL) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
 Financials $13,577 Proxy Form 2026 9 Oct 2026 8:19AM $4.570 $4.930 risen by 7.88%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
 Financials $13,577 Notice of Annual General Meeting 2026 9 Oct 2026 8:19AM $4.570 $4.930 risen by 7.88%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
 Financials $13,577 Becoming a substantial holder 2 Oct 2026 8:17AM $4.510 $4.930 risen by 9.31%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
 Financials $13,577 Ceasing to be a substantial holder 1 Oct 2026 8:13AM $4.620 $4.930 risen by 6.71%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
 Financials $13,577 Becoming a substantial holder 30 Sep 2026 8:18AM $4.550 $4.930 risen by 8.35%
Medibank Private Limited (MPL)
ORDINARY FULLY PAID
 Financials $13,577 Ceasing to be a substantial holder 29 Sep 2026 8:09AM $4.550 $4.930 risen by 8.35%

MPL Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $674.48 $24.49 6.40% 16.17 19.50 4.92% 100.0%
2025F $633.91 $23.02 29.80% 17.20 18.50 4.67% 100.0%
2024A $570.10 $17.74 -4.40% 20.30 16.60 4.61% 100.0%

MPL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
Generation Development Group Limited (GDG) $1,331M -0.4398 0.3827 0.2592 40.0972 28.9982 23.0286 0.61% 0.86% 1.30%
Medibank Private Limited (MPL) $13,302M 0.2486 0.0805 0.0386 19.5467 18.0899 17.4180 3.98% 4.45% 4.77%
NIB Holdings Limited (NHF) $3,253M -0.0922 0.1341 0.1267 17.6377 15.5524 13.8039 5.13% 4.53% 5.06%

MPL Directors

Name Position Start Date
Mr David Koczkar Chief Executive Officer, Managing Director 17 May 2021
Ms Kathryn Joy Fagg Non-Executive Director 31 Mar 2022
Dr Lisa Margaret McIntyre Non-Executive Director 19 Nov 2025
Ms Jacqueline Cherie Hey Non-Executive Director 19 Nov 2025
Mr Peter Dobie Everingham Non-Executive Director 31 Mar 2022
Dr Tracey Leigh Batten Non-Executive Director 28 Aug 2017
Mr Gerard Dalbosco Non-Executive Director 21 May 2021
Mr Michael (Mike) John Wilkins Non-Executive Director, Non-Executive Chairman 25 May 2017

Medibank Private Limited (MPL) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
24 Aug 2026 HEY, Jacqueline Buy Indirect Shares 14,000 $1.000 $14,000.000
2 Mar 2026 HEY, Jacqueline Buy Indirect Shares 11,448 $4.420 $50,600.160
27 Feb 2026 EVERINGHAM, Peter Buy Indirect Shares 25,000 $4.410 $110,250.000

See all changes in directors' interest & trades for Medibank Private Limited (MPL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

MPL Management

Name Position
Mei Ramsay Group General Counsel,Company Secretary
Robert Read Group Lead - Amplar Health
Mark Rogers Group Lead - CFO & Group Strategy
Felicia Trewin Group Lead - Data & Technology
Milosh Milisavljevic Group Lead - Other Executive Office
Kylie Bishop Group Lead - People, Spaces & Sustainability
Meaghan Telford Group Lead - Policy, Advocacy & Reputation

MPL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Medibank Private Limited (MPL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
275,641,770 (10.01%) Australiansuper Pty Ltd
229,260,406 (8.32%) State Street Corporation and subsidiaries
193,895,716 (7.04%) BlackRock Group
193,021,153 (7.01%) The Vanguard Group,Inc
142,685,723 (5.18%) JPmorgan Chase & Co. and its affiliates

MPL Calendar of Events

Date Event
15 September 2027 Report (Annual)
19 August 2027 Report (Prelim)
18 February 2027 Report (Interim)
18 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.